EDITORIAL
Published on 11 Apr 2024
Editorial: Peptidases as a therapeutic target in anti-cancer management
doi 10.3389/fphar.2024.1394018
- 478 views
- Frontiers in Pharmacology
- Pharmacology of Anti-Cancer Drugs
- Research Topics
- Peptidases as a therapeutic target in anti-cancer management
Peptidases as a therapeutic target in anti-cancer management
5,142
Total downloads
34k
Total views and downloads
Submit your idea
Select the journal/section where you want your idea to be submitted:
Articles
ORIGINAL RESEARCH
Published on 05 Dec 2023
Evaluation of variable new antigen receptors (vNARs) as a novel cathepsin S (CTSS) targeting strategy
doi 10.3389/fphar.2023.1296567
- 1,202 views
- 1 citation
ORIGINAL RESEARCH
Published on 06 Nov 2023
Cathepsin V regulates cell cycle progression and histone stability in the nucleus of breast cancer cells
doi 10.3389/fphar.2023.1271435
- 1,939 views
- 7 citations
ORIGINAL RESEARCH
Published on 29 Jun 2023
Novel structured ADAM17 small-molecule inhibitor represses ADAM17/Notch pathway activation and the NSCLC cells’ resistance to anti-tumour drugs
doi 10.3389/fphar.2023.1189245
- 1,946 views
- 1 citation
ORIGINAL RESEARCH
Published on 16 Aug 2021
USP5 Sustains the Proliferation of Glioblastoma Through Stabilization of CyclinD1
doi 10.3389/fphar.2021.720307
- 4,479 views
- 26 citations
ORIGINAL RESEARCH
Published on 01 Jul 2021
Evidence of Omics, Immune Infiltration, and Pharmacogenomic for SENP1 in the Pan-Cancer Cohort
doi 10.3389/fphar.2021.700454
- 5,832 views
- 14 citations
Published in
Frontiers in Pharmacology
- Pharmacology of Anti-Cancer Drugs
Participating Journals
Frontiers in Oncology
- 3.5 impact factor
- 6.2 citescore
Impact
- 34kTopic views
- 13kArticle views
- 5,142Article downloads